Related Experiment Video
Updated: Aug 14, 2026
07:23
Improved Rodent Model of Myocardial Ischemia and Reperfusion Injury
Published on: March 7, 2022
The role of catecholamines in ischemia
1Department of Cardiology, University of Heidelberg, Germany.
Journal of Cardiovascular Pharmacology
|January 1, 1990
Summary
In myocardial ischemia, local norepinephrine release, not central sympathetic activity, drives cell injury and arrhythmias. Adenosine initially limits this, but later, reversed uptake causes dangerous catecholamine buildup.
Area of Science:
- Cardiovascular Physiology
- Neurocardiology
- Ischemic Pathophysiology
Background:
- Myocardial ischemia involves sympathetic nervous system activity, impacting cell injury and arrhythmias.
- Local norepinephrine concentrations, rather than plasma levels, are key in ischemic myocardium.
- Early ischemia involves efferent sympathetic nerve activation, with adenosine limiting norepinephrine release.
Purpose of the Study:
- To investigate the mechanisms of norepinephrine accumulation in ischemic myocardium.
- To determine the role of local metabolic release versus central sympathetic activity in ischemia-induced damage.
- To understand the impact of catecholamine excess and myocyte sensitization on arrhythmias.
Main Methods:
- Studies involved acute and chronic sympathetic denervation.
- Use of antiadrenergic agents to assess norepinephrine release mechanisms.
- Measurement of extracellular norepinephrine concentrations and adrenergic receptor expression.
Main Results:
- After 10 minutes of ischemia, local metabolic release of norepinephrine becomes dominant.
- This release is independent of central sympathetic activity and extracellular calcium.
- Extracellular norepinephrine levels increase 1,000-fold within 20 minutes; myocytes show temporary supersensitivity to catecholamines.
Conclusions:
- Local metabolic norepinephrine release critically contributes to ischemic cell damage and ventricular fibrillation.
- High norepinephrine concentrations combined with enhanced myocyte responsiveness accelerate irreversible cell damage.
- Inhomogenous catecholamine distribution promotes malignant arrhythmias by exacerbating electrophysiological disturbances.
Related Concept Videos
01:27Adrenergic Neurons: Neurotransmission
Postganglionic sympathetic fibers (except those supplying the sweat glands) releasing noradrenaline or norepinephrine are called noradrenergic or adrenergic neurons. Noradrenaline, dopamine, adrenaline, or epinephrine are collectively called "catecholamines" as they contain a catechol moiety and an amine side chain. The five stages of neurotransmitter release involve their synthesis, storage, release, reuptake and metabolism.
Synthesis: Catecholamine synthesis requires tyrosine, which is taken...
Synthesis: Catecholamine synthesis requires tyrosine, which is taken...
01:30Adrenergic Agonists: Direct-Acting Agents
Drugs that mimic the action of endogenous catecholamines like noradrenaline and adrenaline are called adrenergic agonists or sympathomimetics. Based on their mechanism of action, sympathomimetics can be classified as direct-, indirect-, or mixed-acting sympathomimetics. Direct-acting adrenergic agonists activate adrenoceptors without affecting presynaptic neurons, making them independent of neuronal catecholamine-depleting agents like reserpine and guanethidine.
These agents can be classified...
These agents can be classified...
01:25Adrenergic Agonists: Indirect-Acting Agents
Indirect-acting adrenergic agonists potentiate the effects of endogenous catecholamines through different mechanisms without directly binding to adrenoceptors.
One mechanism involves depleting stored catecholamines by displacing them from synaptic vesicles. These agents, known as "displacers," are transported into vesicles at the expense of noradrenaline. Examples include amphetamine and tyramine, which lack a catechol moiety, resulting in prolonged action, improved oral bioavailability, and...
One mechanism involves depleting stored catecholamines by displacing them from synaptic vesicles. These agents, known as "displacers," are transported into vesicles at the expense of noradrenaline. Examples include amphetamine and tyramine, which lack a catechol moiety, resulting in prolonged action, improved oral bioavailability, and...
01:30Adrenergic Agonists: Therapeutic Uses
Adrenergic agonists have diverse therapeutic uses across various medical conditions and emergencies.
Emergency and Intensive Care Unit (ICU) applications: Pressor agents increase blood pressure, heart rate, and contractility in shock and organ failure situations. Dopamine can induce vasodilation and stimulate adrenoceptors. Endogenous catecholamines are effective in treating cardiogenic shock. α2-agonists like clonidine can reverse anesthesia-induced hypertension.
Allergies and anaphylaxis:...
Emergency and Intensive Care Unit (ICU) applications: Pressor agents increase blood pressure, heart rate, and contractility in shock and organ failure situations. Dopamine can induce vasodilation and stimulate adrenoceptors. Endogenous catecholamines are effective in treating cardiogenic shock. α2-agonists like clonidine can reverse anesthesia-induced hypertension.
Allergies and anaphylaxis:...
01:16Antianginal Drugs: Nitrates and β-Blockers
In cardiovascular health, antianginal drugs combat angina pectoris — a condition marked by chest pain owing to diminished blood flow to the heart.
Organic nitrates, such as nitroglycerin, play a pivotal role. Once metabolized, they liberate nitric oxide, a molecular marvel. Nitric oxide triggers guanylyl cyclase and augments cGMP production. This biochemical cascade orchestrates the relaxation of vascular smooth muscles, ushering in vasodilation and enhancing coronary blood flow. Administered...
Organic nitrates, such as nitroglycerin, play a pivotal role. Once metabolized, they liberate nitric oxide, a molecular marvel. Nitric oxide triggers guanylyl cyclase and augments cGMP production. This biochemical cascade orchestrates the relaxation of vascular smooth muscles, ushering in vasodilation and enhancing coronary blood flow. Administered...
01:15Ischemic Stroke ll: Pathophysiology
An ischemic stroke occurs when a cerebral blood vessel becomes obstructed, most often by a thrombus or embolus, interrupting the delivery of oxygen and glucose to brain tissue. Because neurons rely on continuous aerobic metabolism, energy failure begins within minutes of reduced perfusion. The region receiving the least blood flow becomes the infarct core, an area of irreversible cellular death. Surrounding this core lies the penumbra, a zone of hypoperfused but still viable tissue that is...